初冬时节，河南省方城县拐河镇玄参田里机械轰鸣穿梭，药农们忙着抖土、分拣、装车，脸上洋溢着丰 收的喜悦。 "今年流转了150多亩地种玄参，药材长势好，每亩纯收入在2500元左右！明年打算继续扩大种植规 模。"拐河镇杓留村种植大户史向国话语间满是干劲。 方城县地处伏牛山与桐柏山环抱之中，独特的地理条件孕育了丹参、黄芪、玄参等多种道地药材。其 中，裕丹参以参条粗壮、色泽紫红、药效显著闻名，被医圣张仲景誉为"丹参之首"，获评国家地理标志 保护产品。近年来，该县将中医药产业作为特色主导产业，通过强化顶层设计、推进标准化种植、深化 科技赋能、完善利益联结机制，推动产业从传统种植向全链条升级，年产值已突破15亿元，成为乡村振 兴的"黄金引擎"。 科技赋能为产业发展注入强劲动力。在杨集镇现代中医药产业园，智慧繁育中心内的育苗盘整齐排列， 裕丹参种苗绿意盎然。"我们采用智能工厂化育苗技术，实时监测控制大棚温湿度、水肥等数据，不仅 缩短了育苗周期，还让种苗成活率和抗病虫害能力大幅提升。"杨集镇宣传委员温要广介绍。 除此之外，依托与河南中医药大学、河南农业大学的产学研合作，方城县突破丹参种质资源研发瓶颈， 成功培育出高产、抗旱抗寒 ...

Core Insights - The 56th National Medicinal Materials and Pharmaceuticals Trade Fair opened in Zhangshu City, Jiangxi, featuring over 1,000 pharmaceutical companies, including more than 40 of China's top pharmaceutical enterprises [1] - The theme of the conference is "Inheriting Essence, Improving Quality, and Innovating," showcasing nearly 1,000 products across the entire industry chain, including traditional Chinese medicine, proprietary Chinese medicines, pharmaceutical equipment, and health products [1] - The event includes 12 specialized exhibition areas, with a new section dedicated to the transfer of innovative drug approvals, aimed at connecting approval holders with production companies [1] Industry Developments - A promotional meeting for investment attraction in Jiangxi's pharmaceutical industry was held, resulting in the signing of 10 projects across various sectors, including medical devices, pharmaceutical chemicals, traditional Chinese medicine cultivation, and new drug research and development [1] - Zhangshu City is implementing the "China Medicine Capital" revitalization project, transitioning the traditional Chinese medicine industry from "traditional processing" to "modern manufacturing" and enhancing the value of medicinal materials [1] - The city currently has over 500 pharmaceutical companies, including 50 national high-tech enterprises in the pharmaceutical sector, and has been recognized as a four-star national new industrialization industry demonstration base [1]

Core Points - Zhejiang Shouxiangu Pharmaceutical Co., Ltd. announced that its wholly-owned subsidiary, Jinhua Shouxiangu Pharmaceutical Co., Ltd., has completed the re-registration of its health food product, "Shouxiangu Brand Ganoderma Spore Oil Soft Capsules," and received the registration certificate from the State Administration for Market Regulation [1][2][3] - The successful re-registration ensures the normal production and sales of the product, playing a crucial role in stabilizing the company's product system [1] - The company will continue to adhere to its established plans, focusing on its core business, leveraging existing industry advantages, and targeting cutting-edge technology in traditional Chinese medicine [1] - The company aims to conduct in-depth research and development on precious traditional Chinese medicinal materials such as Ganoderma, Dendrobium, and Saffron, to achieve product transformation and upgrade, thereby strengthening its core business [1]

Group 1 - The Agricultural Bank of China Bozhou Branch reported a new loan increase of 5.77 billion yuan in Q1 2025, serving over 9,000 enterprises and business entities, leading the city's banking sector in both loan growth rate and volume [1] - The bank has implemented innovative financial services to support rural revitalization, including the launch of specialized products like "Huinong e-loan" and "Liangnong e-loan," which have significantly contributed to agricultural financing [2] - The bank's agricultural loan balance increased by 3.418 billion yuan year-to-date, with rural industry loans accounting for an additional 2.905 billion yuan, providing a financial model for agricultural industrialization in northern Anhui [2] Group 2 - The bank is aligning with the strategy to build a "World Capital of Traditional Chinese Medicine," creating a full industry chain service system for the TCM sector, and has issued over 100 million yuan in specialized loans to support leading enterprises [3] - The TCM industry loan balance reached 2.034 billion yuan, with a net increase of 459 million yuan, serving 1,884 pharmaceutical companies and merchants [3] - The bank has established a full lifecycle service system for high-tech enterprises, providing 10 million yuan in special credit to support the production line of a vacuum technology company, with a technology loan balance of 1.511 billion yuan, growing over 52.78% [4] Group 3 - The bank's total deposits and loans reached 51.5 billion yuan by the end of Q1, with inclusive loans and loans to farmers leading the local financial system in growth [4] - The bank aims to deepen financial reform and innovation, focusing on supporting the development requirements of northern Anhui [4]